Swedencare AB : Technically solid
Entry price | Target | Stop-loss | Potential |
---|
SEK 61.7 |
SEK 79 |
SEK 51 |
+28.04% |
---|
Swedencare AB shares show a positive technical situation which suggests a continuation of the upward dynamic over the medium term.
Summary● The company has a poor ESG score according to Refinitiv, which ranks companies by sector.
Strengths● The company's profit outlook over the next few years is a strong asset.
● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
● Over the past year, analysts have regularly revised upwards their sales forecast for the company.
● Sales forecast by analysts have been recently revised upwards.
● Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 41.83 times its estimated earnings per share for the ongoing year.
● With an enterprise value anticipated at 3.96 times the sales for the current fiscal year, the company turns out to be overvalued.
● The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
● Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.